Tech Company Financing Transactions
Aortyx Funding Round
On 6/12/2025, Aortyx raised $16 million in Series A investment from Clave, Ship2B Ventures and CDTI.
Transaction Overview
Company Name
Announced On
6/12/2025
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Clave (Lead Investor) (Sergio Agustín)
Ship2B Ventures (Lead Investor) (Jordi Ferrer)
Proceeds Purpose
The funding will be used to reach the milestone of first-in-human testing, bringing their product, a bioresorbable patch that treats aortic tears, closer to market.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Barcelona, Undisclosed
Spain
Barcelona, Undisclosed
Spain
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Aortyx is a pioneer company founded in 2018 by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. With an initial focus on treating aortic dissection, Aortyx is developing a family of biomimetic, bioresorbable endovascular patches that are deployed via a specialized aortic catheter. The patches are designed to adhere to the vessel wall, and to promote natural repair of the aorta and biointegration within the native tissue.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jordi Martorell
Browse more venture capital transactions:
Prev: 6/12/2025: Perscient venture capital transaction
Next: 6/13/2025: Engrate venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs